BMS catches flak for closing French factory; Biogen to lose COO at year's end;

  @FiercePharma: Pfizer tops drug-sampling list with $2.7B in spending. Report | Follow @FiercePharma

> An international group that helps ensure patient access to HIV drugs is warning that Bristol-Myers Squibb's (NYSE: BMY) plans to close a French factory could leave thousands of babies without a life-saving treatment. Report

> Genzyme says it has nominated Dennis Fenton, a former executive vice president at biotechnology company Amgen, to its board of directors. Release | Report

> Astellas Pharma says it has successfully completed its $4 billion tender offer for OSI Pharmaceuticals, receiving offers for 93 percent of the U.S. cancer drug-developer's outstanding shares. Report

> Buoyed by its recent $3.72 billion acquisition of Piramal Healthcare's solutions business, Abbott Laboratories is expecting sales in India to exceed $2.5 billion by 2020. Report

> Bosnia's Muslim-Croat federation will not rush with a new auction of its stake in top drugs firm Bosnalijek after a previous transaction failed, the privatization agency said. Report

> Ranbaxy Laboratories says its unit has launched atorvastatin, a generic form of Pfizer's blockbuster Lipitor cholesterol fighter, in South Africa. Report

> APP Pharmaceuticals says it has won FDA approval to market oxaliplatin, the generic version of Sanofi-Aventis' cancer drug Eloxatin. Report

> Chinese drugmaker Simcere Pharmaceutical said it is taking a larger stake in a company that makes injectable stroke-management drugs. Release | Report

 Biotech News

 @FierceBiotech: BMS, Pfizer cancer drugs take starring roles at ASCO. Article | Follow @FierceBiotech

 @JohnCFierce: WHO chief denies private co.s influenced pandemic plan, won't name advisers. Secrecy will always inspire distrust. Report | Follow @JohnCFierce

> Forest Labs scoops up diabetes programs in $1.1 billion TransTech deal. News

> Biogen board promises to name a new CEO soon. Report

> Sanofi CEO: Still in the hunt for new drug deals. Article

> Merck KGaA resubmits oral MS drug to FDA. Story

 Biotech Research News

> Cholesterol levels are 'remotely' controlled by ghrelin. Story

> Inhibiting key enzyme will reduce deaths from septic shock. Item

> Harvard spinoff promises genome sequencing for $30. News

> RNA institute to be unveiled at Albany school. Story

> George Church takes lead role commercializing genomics. Report

Manufacturing News

> Cambrex automates plant processes. Article

> GSK, academics team to print APIs onto tablets. News

> USGS: Pharma facilities release contaminants. Report

> J&J hands Congress 20K pages of Tylenol documentation. Story

> GSK rolls out 2D data-matrix system. News

And Finally... Dengue fever has re-entered the U.S. via the Florida Keys after an absence of 65 years. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.